We are live on ! Find out more
SNTI icon

Senti Biosciences Holdings
SNTI

44 hedge funds and large institutions have $202M invested in Senti Biosciences Holdings in 2021 Q2 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

8.8% more ownership

Funds ownership: 0% → 8.8% (+8.8%)

Holders
44
Holders Change
+44
Holders Change %
–
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
44
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$29.9M
2
Morgan Stanley
Morgan Stanley
New York
+$28.9M
3
AIM
ARK Investment Management
Florida
+$20.8M
4
RG
Redmile Group
California
+$20.1M
5
WP
Woodline Partners
California
+$20M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
26
Tenor Capital Management
New York
$1.01M +$1.02M +10,200 New
ICM
27
III Capital Management
Florida
$994K +$998K +10,000 New
JGC
28
J. Goldman & Co
New York
$994K +$998K +10,000 New
MTCM
29
Mint Tower Capital Management
Netherlands
$994K +$998K +10,000 New
SCM
30
Segantii Capital Management
Hong Kong
$994K +$998K +10,000 New
CCM
31
CAAS Capital Management
New York
$923K +$927K +9,290 New
TD Asset Management
32
TD Asset Management
Ontario, Canada
$863K +$875K +8,770 New
Goldman Sachs
33
Goldman Sachs
New York
$820K +$823K +8,250 New
DCM
34
Dupont Capital Management
Delaware
$696K +$698K +7,000 New
Tudor Investment Corp
35
Tudor Investment Corp
Connecticut
$497K +$499K +5,000 New
Geode Capital Management
36
Geode Capital Management
Massachusetts
$339K +$341K +3,416 New
CC
37
Centiva Capital
New York
$336K +$337K +3,382 New
GCL
38
Glazer Capital LLC
New York
$216K +$217K +2,176 New
Voloridge Investment Management
39
Voloridge Investment Management
Florida
$116K +$116K +1,164 New
PAM
40
Panagora Asset Management
Massachusetts
$106K +$107K +1,068 New
Bank of America
41
Bank of America
North Carolina
$14K +$14.3K +143 New
MF
42
Magnetar Financial
Illinois
$5.96K +$5.99M +60,000 New
JP Morgan Chase
43
JP Morgan Chase
New York
$1K +$998 +10 New
Toronto Dominion Bank
44
Toronto Dominion Bank
Ontario, Canada
– +$299 +3 New
1
2

SNTI Hedge Fund Activity: Q2 2021 in Review

44 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q2 2021, worth a combined $202M.

Buyers outnumbered sellers: 44 funds opened new SNTI positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $29.9M.

  • 44 institutional investors held Senti Biosciences Holdings (SNTI) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $202M of Senti Biosciences Holdings stock for Q2 2021.
  • 44 funds opened new Senti Biosciences Holdings positions in Q2 2021 and 0 closed out, a net change of +44 holders.
  • The largest Senti Biosciences Holdings buyer in Q2 2021 was T. Rowe Price Associates, an estimated $29.9M added.

Based on aggregated 13F filings for Q2 2021.